Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril for Persistent Developmental Stuttering
NCT04173949Phase 3Active, not recruiting
- Sponsor
- Emek Medical Center
- Start
- Mar 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramipril in developmental stuttering, sponsored by Emek Medical Center. Started Mar 2020; status: active, not recruiting.
02
Drugs
ramipril
03
Conditions
developmental stuttering
Beyond the preview
Go deeper on NCT04173949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173949.